Workshop Date and Time
Monday, May 24, 2021, 1:30 – 2:30 pm, Eastern Time Register Now
Registrants can listen in live over the phone or online as a webcast.
- Why Diagnostic Technologies Are Important for Blood Cancers, in the Context of COVID-19
- How They Contribute to & Transform Your Blood Cancer Treatments
- New & Emerging Diagnostic Technologies
- How to Participate in Blood Cancer Clinical Trials
- Specific Questions to Ask the Healthcare Team about Diagnostic Technologies
- Accessing Resources for Blood Cancer Clinical Trials
- Guide to Preparing for Your Telehealth/Telemedicine Appointments, including Technology & List of Prepared Questions
- Questions for Our Panel of Experts
Our Panel of Experts
Peter Martin, MD
Chief, Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian Hospital
Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine
William I. Bensinger, MD
Center for Blood Disorders and Stem Cell Transplantation, SCI’s Personalized Medicine Program, Myeloma & Transplant Program, Swedish Cancer Institute
Ruben A. Mesa, MD, FACP
Executive Director, Mays Cancer Center at UT Health San Antonio MD Anderson, Mays Family Foundation Distinguished University Presidential Chair, Professor of Medicine, UT Health San Antonio Cancer Center – An NCI Designated Cancer Center
Elizabeth K. O’Donnell, MD
Director, Lifestyle Clinic, Massachusetts General Hospital, Associate Director, Mass General Cancer Center’s Survivorship Program, Assistant Professor of Medicine, Harvard Medical School
Joseph Khoury, MD, FCAP
Professor, Division of Pathology & Lab Medicine, Department of Hematopathology, Medical Director, Clinical Expansion, Division of Pathology & Lab Medicine, Executive Director, MD Anderson Cancer Network, Division of Pathology & Lab Medicine, The University of Texas M. D. Anderson Cancer Center
Sarah Thibault-Sennett, PhD
Senior Manager of Public Policy and Advocacy, Association for Molecular Pathology (AMP)
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
CancerCare, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).
To request continuing education paperwork, please email your name, profession, and address to email@example.com after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.
You can download the brochure for this workshop(96.3 KB)